Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 07-1999 | 04-1999 | 01-1999 | 10-1998 | 07-1998 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 630 | 720 | 690 | 560 | 670 |
| Receivables | 1 | 1 | 20 | 0 | 1 |
| Inventories | 20 | 20 | 60 | 60 | 50 |
| Other current assets | 229 | 209 | 220 | 230 | 229 |
| TOTAL | $880 | $950 | $990 | $850 | $950 |
| Non-Current Assets | |||||
| PPE Net | 1,110 | 1,110 | 1,100 | 1,100 | 1,100 |
| Investments And Advances | 160 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 10 | 10 | 10 | 10 | 10 |
| TOTAL | $1,280 | $1,120 | $1,110 | $1,110 | $1,110 |
| Total Assets | $1,420 | $1,350 | $1,370 | $1,240 | $1,350 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 100 | 30 | 120 | 50 | 50 |
| Accrued Expenses | 30 | 30 | 30 | 20 | 40 |
| Other current liabilities | 340 | 340 | 340 | 270 | 280 |
| TOTAL | $480 | $420 | $500 | $340 | $370 |
| Non-Current Liabilities | |||||
| Long Term Debt | 10 | 0 | 0 | 0 | 0 |
| TOTAL | $30 | $30 | $20 | $20 | $20 |
| Total Liabilities | $520 | $460 | $520 | $370 | $400 |
| Shareholders' Equity | |||||
| Common Shares | 9 | 9 | 9 | 9 | 8 |
| Retained earnings | -4,970 | -4,990 | -5,020 | -5,000 | -4,910 |
| Other shareholders' equity | 531 | 551 | 561 | 561 | 562 |
| TOTAL | $900 | $880 | $850 | $870 | $960 |
| Total Liabilities And Equity | $1,420 | $1,340 | $1,370 | $1,240 | $1,360 |